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Abstract 
Aim: Patients with incipient hip arthrosis may benefit from a relatively new therapeutical approach using resurfacing total 
hip replacement, but in those with associated osteoporosis, this type of surgical intervention is contraindicated, given the poor quality 
of osteoporotic bones. We assessed the efficacy of the antiosteoporotic pharmacological therapy to improve bone quality and bone 
strength in postmenopausal women diagnosed with hip arthrosis and osteoporosis thus facilitating the hip surgical intervention. 
Methods: We evaluated 20 postmenopausal women aged between 53-60 years diagnosed with osteoporosis according to 
the WHO criteria, by using dual-energy X-ray absorptiometry (DXA) for bone mineral density measurements. All these patients had 
low hip T score (osteopenia/ osteoporosis) and also incipient hip arthrosis. The surgical approach was delayed for 12 months and all 
the patients received bisphosphonate therapy with calcium and vitamin D supplements. DXA scans were performed after 12 months 
of therapy in all the patients. 
Results: A surgical intervention with resurfacing total hip replacement was performed in 12 of the 16 patients presenting 
with increasing BMD, 4 of them showing elements of rapidly advancing hip arthrosis to a stage that made this type of intervention 
impossible. We chose not to use this technique in the group with stable BMD (4 patients). All 12 women surgically treated had a 
favorable post-operative outcome without experiencing a femoral neck fracture during the surgical intervention or during the twelve-
month follow-up. All 20 patients continued to receive bisphosphonate therapy. 
Conclusion: In postmenopausal women with osteoporosis and associated hip arthrosis, improving bone mass and bone 
quality with  bisphosphonate therapy is necessary and important in order to allow hip arthroplasty, by using the technique of 
resurfacing, avoiding the risk of intra-operative fractures and  with a favorable  post-operative long-term  outcome. 
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Introduction 
In the modern sense, osteoporosis is defined as 
a systemic skeletal disease characterized by low bone 
mass and deterioration of the bone microarchitecture, 
resulting in increased bone fragility and predisposition to 
fracture. Osteoporosis is currently the most frequent 
metabolic bone disease, a more recent definition 
correlating this skeletal disease with the alteration of the 
bone strength, reflecting both bone density, and bone 
quality. 
Significant progress has been made in recent 
years not only in defining this public health problem, but 
also in identifying the multiple pathogenic mechanisms 
underlying the occurrence of osteoporosis, enabling 
interventional strategies to reduce the morbidity and 
mortality associated with it, as well as to decrease the 
significant socio-economic costs involved by osteoporosis 
in the context of the increase of life expectancy and 
consequently, the increase of the population at risk for 
this disease. 
The aging process and/or estrogen deficiency 
remain the main pathophysiological links involved in the 
loss of bone mass in primary osteoporosis: involutional 
and postmenopausal. After the age of 40, as one ages, 
the loss of bone capital is of approximately 0.5% -1% per 
year, in women the occurrence of menopause leading to a 
more accelerated rate of bone loss of 1% -2% per year, 
especially in the first 5-10 years of menopause. The 
occurrence of menopause at the bone level has the effect 
of a substantial increase in the remodeling process which 
results in a significant negative bone impact, causing loss 
of bone mass. During postmenopause, the loss of bone 
mass has two stages: an initial stage characterized by an 
accelerated - predominant loss of trabecular tissue, 
followed by a stage during which the loss continues, but Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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at a lower rate and especially at the level of the cortical 
bone. 
The initial stage is recorded in the first 5-10 
years after the occurrence of menopause and is 
materialized in the loss of approximately 20% -30% of the 
trabecular bone and of only 5% -10% of the cortical bone. 
During this stage, remodeling takes place mainly at the 
level of the endosteal surface, thus explaining the loss of 
the trabecular bone. The evaluation of the biochemical 
markers of the bone turnover seems to indicate that at the 
time of the menopause  the bone resorption markers 
increase by 90%, whereas the bone formation markers 
only increase by 45%. 
In the next stage, the loss of bone mass 
continues, but at a lower rate, being associated with the 
progressive increase of the seric value of the parathyroid 
hormone and of the bone turnover markers, the studies 
suggesting a causal relationship between these two 
biological changes. 
The imaging techniques used for the diagnosis 
of osteoporosis are based on the measurement of the 
bone mineral density and of the bone mineral content. 
Dual-energy X-ray absorptiometry (DXA) is currently the 
most widely used technique and it is considered the “gold 
standard’ in diagnostic means, enabling not only the 
diagnosis, but also the monitoring of the loss of bone 
mass, as well as the effectiveness of the various drug 
strategies employed.  
Material and method 
In recent years, the number of postmenopausal 
women with osteoporosis has increased. At the same 
time, the age at which surgery is indicated in coxarthrosis 
has decreased, increasingly younger people choosing 
total hip replacement instead of a conservative treatment. 
One of the most modern techniques in hip arthroplasty is 
the resurfacing one, which preserves a large bone capital, 
which has a lower risk of dislocation caused by wide 
movement (due to the large head of the prosthesis) and a 
longer life (due to the lower friction forces given by the 
metal-on-metal hip replacement). Moreover, the revision 
of such prosthesis often consists only in the replacement 
of the femoral component with a classical stem-shaft 
which should preserve the metal-on-metal hip 
replacement with a large diameter femoral head. The 
resurfacing endoprosthesis is a new method, distinctly 
superior to the endoprosthesis techniques used, from the 
point of view of the immediate and distance post-
operative recovery, followed by the full resumption of the 
function of the pelvic limb and a minimum rate of 
postoperative complications. The performances of this 
prosthesis are obvious in well selected cases (young 
patients with intense physical activity) after a surgical 
indication correctly formulated. 
During the period 2005-2010, 22 total hip 
replacements were performed in the Clinic of Orthopedics 
and Traumatology of the University Emergency Hospital 
of Bucharest, in patients younger than 60 with NACF 
(aseptic femoral head necrosis) primary or secondary 
coxarthrosis in the initial stage and postmenopausal 
osteoporosis. The following were used as investigation 
methods: hip X-rays - two incidents (front and profile), 
pelvis MRI (Figure 1) and DXA. After setting the 
diagnosis, the surgical procedure was delayed for six 
months, during which the patients received a conservative 
treatment for coxarthrosis and treatment with 
bisphosphonates to increase BMD. X-ray examinations 
and DXA at 0.3 and 6 months preoperatively were 
performed. 
Results 
Resurfacing total hip replacements were 
performed on 14 patients, in whom an increase in BMD 
over 1.5 at the DXA examinations performed every 0 to 6 
months was found and in whom the evolution of hip 
arthritis was slow. In six patients’ treatment with 
bisphosphonates the bone quality did not improve 
sufficiently and in two cases of aseptic femoral head 
necrosis, the disease progressed rapidly and did not allow 
the implantation of a resurfacing prosthesis. 
 
Regarding the perioperative planning, the following 
stages were followed: 
As a standard method of investigation a hip X-
ray in the anterior-posterior incidence was performed in a 
1/1 ratio, on which the preoperative planning was 
performed to determine the size of the implant (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 
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           Fig. 2 
 
The approach was posterolaterally made, with 
the patient placed in lateral decubitus. After the incision of 
the external rotator muscles, full capsulotomy was 
performed. The femoral head was turned and positioned 
in the anterior-superior part of the cotiloid cavity to 
facilitate its preparation by milling. As a rule, the milling is 
performed so as to achieve a diameter smaller than 2 
mm, than the acetabular prosthetic component, which has 
to be implanted. The preparation of the femoral head is 
performed by using a guidance to center the stem, then 
for the reversed mills (Figure 3). 
Intraoperatively, three factors are taken into 
consideration when deciding the type of implantation of a 
resurfacing prosthesis: 
- the damage to the femoral head of < 35% 
- the normal appearance of the junction between 
the femoral head and the femoral neck 
- sufficient bone capital remaining at the level of 
the femoral head to ensure the stability of the stem. 
The fixation of the stem is performed by using 
low-viscosity cement (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           Fig. 4 
 
All the patients were administered antithrombotic 
prophylaxis, with heparin administered subcutaneously, 
starting with the day of the surgery until the 45th day of 
post-operative care.  
The immediate postoperative results were good 
in all cases, the patients having an early motor recovery. 
The patients were mobilized with progressive loading by 
means of a walking frame during the first seven days, 
then were fully loaded by using the help of two crutches 
for another seven days, giving up one of the crutches 
before the 21st day. One month postoperatively they were 
mobilized with full loading without support, the 
movements being mostly recovered. The recovery was 
rapid, within a short period of time the patients being able 
to make complex movements of normal amplitude. They 
resumed normal activity (work, sports) 6-8 weeks 
postoperatively. 
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All the patients were followed up clinically and 
radiologically (Figure 5) at 4 weeks, 6 weeks, 3 months, 6 
months, 12 months, then annually. 
 No femoral neck fractures were reported, both 
during surgery and during the first 12 months after 
surgery, the patients benefitting from all the advantages of 
a resurfacing prosthesis. 
  The patients continued to receive the treatment 
with bisphosphonates for the treatment of osteoporosis. 
Discussions 
The use of the resurfacing total hip prosthesis 
brings real benefits to the patients. Out of all these, the 
most important are: 
  - the preservation of the femoral head and 
femoral canal, thus avoiding the loss of capital bone in the 
event of a review. 
 - the large size of the stem significantly reduces 
the risk of dislocation 
  - the quick, complete post-operative recovery 
with the normal motility of the hip joint 
 - the physiological transmission of the forces at 
the level of the femoral canal by means of the femoral 
head and neck 
 - the metal-on-metal hip replacement avoids the 
occurrence of the particle disease 
Conclusions 
We recommend the delay of the hip arthroplasty 
in patients with postmenopausal osteoporosis and the 
administration of the treatment with bisphosphonates to 
increase BMD for 12 months, in order to have possibility 
to use a resurfacing prosthesis. Postmenopausal 
osteoporosis successfully treated is not an absolute 
contraindication for resurfacing total hip replacement. The 
introduction of the resurfacing total hip replacement in 
women with moderate osteoporosis has led to an 
increased quality of life postoperatively.  
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